Excessive supragastric belching (SGB) manifests as troublesome belching, and can be associated with refl ux and signifi cant impact on quality of life (QOL). In some GERD patients, SGB-associated refl ux contributes to up to 1/3 of the total esophageal acid exposure. We hypothesized that a cognitive-behavioral intervention (CBT) might reduce SGB, improve QOL, and reduce acid gastroesophageal refl ux (GOR). We aimed to assess the effectiveness of CBT in patients with pathological SGB. Careful analysis of MII-pH allows identifi cation of a subgroup of GERD patients with acid refl ux predominantly driven by SGB. In these patients, CBT can reduce esophageal acid exposure.
INTRODUCTION
Excessive belching is a frequently reported symptom in patients with dyspepsia, gastro-esophageal refl ux disease, and other upper gasterointestinal disorders ( 1, 2 ) .
Esophageal impedance monitoring enables clinicians to identify two distinct types of belching: (a) gastric belching, which involves gastric venting of swallowed air via transient relaxation of the lower esophageal sphincter (TLESR), and (b) supragastric belching (SGB), when air enters and leaves the esophagus rapidly without reaching the stomach ( 3 ).
Both gastric and SGBs occur in asymptomatic healthy subjects. Whereas increased gastric belching is considered to be a consequence of pathological aerophagia, and/ or incompetent antirefl ux barrier in refl ux disease, increased SGB is considered to be the expression of a distinct behavioral disorder ( 4, 5 ) .
Th e prevalence of pathological SGB has recently been estimated at 3.4% among a tertiary referral population for investigation of upper gastrointestinal complaints ( 5 ) .
Patients with pathological SGB can present with excessive belching as a main symptom but can also be associated with heartburn Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal refl ux and regurgitation, rumination syndrome or globus, and aft er antirefl ux surgery (5) (6) (7) .
Patients with SGB oft en report reduced social functioning ( 2 ) . In addition to the psychosocial concerns, SGB can be associated with increased gastroesophageal refl ux. A temporal association between SGBs and acid refl ux has been identifi ed ( 5, 8 ) . In a recent study, 95% of patients identifi ed as having pathological SGB suffered from typical refl ux symptoms. Furthermore, in the subgroup of patients with pathological acid exposure, up to a third of the acid burden was due to acid refl ux episodes temporally associated with SGBs ( 5 ) .
Treatments for pathological SGB include the use of Baclofen alone or in combination with pregabalin ( 9, 10 ) . However, these treatments can be hampered by excessive sedation.
It has been hypothesized that SGB may initially develop as a voluntary response to unpleasant thoracic or epigastric sensations, where the patient performs a SGB to relieve the discomfort ( 8 ) . However, as the SGB response is performed repeatedly over time it may, according to this hypothesis, gradually become an automatic mechanism, with the individual losing conscious control over the belching response ( 11 ) . Th ere are some indications that psychological factors may play a role in SGB. Th ese include the absence of SGB during sleep, the reduction in symptoms when the patient is speaking or distracted, and exacerbation during stressful events (11) (12) (13) .
Encouraging results using cognitive behavioral interventions (CBTs) have been reported to reduce the occurrence of excessive SGB (14) (15) (16) . Th ose studies included a small number of patients, have mainly provided subjective measures of outcomes focusing on belching but less information on the eff ect of treatment on acid gastro-esophageal refl ux.
Th e aim of this study was to assess the eff ectiveness of a standardized protocol of CBT in patients with pathological SGB, and to investigate whether CBT-induced reduction in SGB can decrease acid gastro esophageal refl ux in those with pathological GOR.
METHODS

Subjects
Fift y-one consecutive patients with pathological SGB (>13 SGBs per 24 h) were prospectively enrolled in this study. Th e defi nition of pathological SGB was based on our previous study showing that normal healthy subjects have a median of 3 (range 0-15) SGBs in 24 h. Th e 95th percentile value was taken as the upper limit of normal, and was calculated at 13 SGBs per 24 h ( 5 ). Eligible patients were identifi ed at the Upper gasterointestinal Physiology Unit of the Royal London Hospital, UK aft er completion of a 24 MII-pH study performed at least one week off proton pump inhibitors. Th ese patients had been referred to the gasterointestinal Physiology Unit to have high resolution manometry and MIIpH monitoring as part of their clinical or surgical management of esophageal/extra-esophageal refl ux symptoms and/or increased belching. If pathological SGB was diagnosed, the patient was off ered the possibility to undergo cognitive behavioral therapy provided by our team. Exclusion criteria included non-English speaking patients, a diagnosis of a current major psychiatric disorder, and cognitive or intellectual impairment. Th e CBT treatment was performed as part of the patient's clinical management.
Diagnosis of SGB
We diagnosed SGB using 24 h MII-pH monitoring. A combined MII-pH catheter (Sandhill Scientifi c, Inc, Highlands Ranch, CO, USA) was placed transnasally such that the esophageal pH probe was situated 5 cm above the lower esophageal sphincter. Th e catheter also has eight electrode rings enabling impedance recording at six segments from 3 cm to 17 cm above the lower esophageal sphincter. Tracings were manually analyzed for presence of acid/ non-acid refl ux and SGBs. Meal periods were excluded from analysis. SGBs were identifi ed using criteria described by Bredenoord et al. ( 3 ) (a rapid rise in impedance (≥1000 Ω) moving in an aboral direction, followed by a return to baseline moving in the opposite direction). Acid/non-acid liquid refl ux episodes detected by MII-pH were considered to be associated with SGB if they began within 1 s aft er a SGB episode ( Figure 1 ) . Th e SGB-related percentages of total esophageal acid exposure time (AET) and total number of acid refl ux events were calculated for each patient.
Treatment with cognitive behavioral therapy
Treatment protocol . Patients attended a total of fi ve sessions, including an initial assessment with a gastroenterologist and psychologist, and four sessions of cognitive behavioral therapy. Th e treatment protocol was adapted from that described by Katzka et al. ( 14 ) .
Cognitive component . Th e intervention commenced with psychoeducation of SGB to help the patient understand the condition, the onset and triggering events, and the rationale for using the treatment exercises. A functional analysis of the belching A supragastric belch as seen on impedance: air enters in an aboral direction, and is immediately expelled. Figure 1 . Example of supragastric belching in esophageal impedance recording. A rapid increase in impedance occurs when air moves along the esophagus. In this expanded tracing, the air initially moves in the aboral direction (arrow) and is eliminated by straining in the oral direction resulting in a supragastric belch.
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Supragastric Belching Treatment with Cognitive Behavioral Therapy symptoms was discussed with the patient to identify antecedents and consequences to increase the patient's awareness of the factors contributing to or reinforcing the belching. Th e identifi cation of a 'warning signal' preceding the SGB is considered an important stage to the behavioral treatment of SGB. Patients were asked to identify the physical sensations experienced prior to the belch occurring as a warning signal, with commonly reported sensations of "a feeling of pressure or tension in the foodpipe". Th e increased awareness of the warning signal allowed the patients to recognize this as a cue for using the treatment exercises to prevent the belch from occurring. Awareness training is a technique widely used in habit reversal training during interventions for behavioral disorders. In addition, the patient's thoughts on the belching were explored to highlight any unhelpful thinking patterns linked to the belching, such as that the SGB is helping to relieve heartburn or release air from the stomach. Patients were coached to use self-talk to challenge these unhelpful thoughts and remind themselves to implement the exercises at the appropriate time.
Behavioral component . Th e treatment exercises consisted of teaching the patients (1) diaphragmatic breathing, and (2) mouth opening/tongue position to make SGB diffi cult. Patients were instructed on slow and steady diaphragmatic breathing, inhaling for 3 s and exhaling for 3 s. Th ey were instructed to place both hands on their anterior abdominal wall, and to watch its rise and fall during this process. Patients were then asked to breathe through their mouth with the mouth held moderately open, and if possible placing the tongue behind the top front teeth. Initially this exercise combining the diaphragmatic breathing and mouth position was practised at least twice per day for 3-5 min in a supine or sitting position. Once patients were familiar and confi dent with the diaphragmatic breathing and the position of the mouth, they were instructed to use the exercises daily as oft en as possible to prevent belching. Th is involved recognizing the warning signals identifi ed, and using this signal to immediately start the diaphragmatic breathing and open the mouth, continued until the urge to belch decreased.
Assessment of treatment and outcomes
Objective evaluation . Objective evaluation of outcomes was based on MII-pH before and aft er the fi ve CBT sessions (i.e., at 8 weeks). Parameters analyzed were the number of SGBs, number of gastric belches the total AET, number of acid refl ux episodes, and the proportion of acid refl ux episodes and AET associated with SGBs.
Subjective evaluation . Before CBT treatment, patients completed questionnaires to assess personality traits, hypervigilance, healthrelated quality of life (QOL) (the SF36 survey) belching symptom severity using a four-item visual analog scale (VAS). Aft er treatment (at 8 weeks), patients repeated the VAS and SF-36.
Questionnaires . BFI-10:
Th e BFI-10 is a 10-item version of the Big Five Inventory that assesses personality across the dimensions of extraversion, agreeableness, conscientiousness, neuroticism, and openness ( 17 ) . SSAS: Th e Somatosensory Amplifi cation Scale (SSAS), a 10-item questionnaire, assesses hypervigilance to bodily sensations and the tendency to experience normal somatic sensations as uncomfortable or troubling ( 18 ) . Th e items are rated on a fi ve-point scale from 1 (Not at all true) to 5 (Extremely true) and ratings are summed to produce a total amplifi cation score that ranges from 10 to 50, ( 19 ) with average SSAS scores between 24 and 29; ( 20 ) scores higher than 30 may indicate increased somatization ( 21 ) .
VAS
A four-item VAS adapted from Hemmink et al. ( 9 ) was used to measure subjective changes in belching symptom severity throughout the intervention. Th e VAS questions, rated from 0 (absence of symptoms) to 100 (very severe symptoms), asked patients to rate how bothered they are by their belching, their ability to control belching, the impact of the belching on daily activities, and the impact on social activities. A composite score from 0 (absence of symptoms) to 400 (very severe symptoms) was also reported.
SF-36: Th e Short Form Health Survey (SF-36) assesses eight domains including four physical subscales of physical functioning (daily life limitations due to health problems), bodily pain (pain frequency and interference with normal roles), limitations in fulfi lling physical roles (due to physical health problems), general health (individual perception of health), and four psychological subscales of limitations in fulfi lling emotional roles (due to emotional problems), vitality (energy/fatigue), social functioning (ill health interference with social activities), and mental health (psychological distress). A scoring algorithm is used to convert the raw scores into the eight dimensions listed above. Th e scores are transformed to range from zero (where the respondent has the worst possible health) to 100 (where the respondent is in the best possible health). Data from our patients with SGB were compared against normative data from the ONS Omnibus Survey in Britain ( 22 ) .
Statistical analysis
Th roughout the manuscript data are presented as mean±SEM or SD or median and interquartile range. Th e number of SGBs and VAS scores pre and post CBT were compared using the Wilcoxon signed rank test.
RESULTS
Patients
In total, 51 patients with pathological SGB attended the fi rst CBT explanatory session (51% females, mean age 45, range 20-72). Of these, 12 patients did not complete the CBT protocol (31% female, mean age 44, range 32-54). Reasons being: (a) lack of confi dence in the method ( n =3), (b) traveling diffi culties ( n =5) and (c) preferred other treatments ( n =4).
39 patients fi nished the standardized CBT protocol and had full subjective evaluation with VAS and SF-36 questionnaire ESOPHAGUS VOLUME 113 | APRIL 2018
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scores before and aft er treatment. 31 patients agreed to undergo a second MII-pH monitoring and had both full subjective and objective evaluation before and aft er treatment. Belching was a problematic symptom in all patients. It was the symptom of primary concern in just over half of the patients (56%), followed by heartburn (23%), regurgitation (21%), and abdominal pain (10%).
Effect of treatment on objective outcomes
In patients who had MII-pH monitoring before and aft er CBT treatment, the number of SGBs decreased signifi cantly aft er CBT therapy from a median of 116 (47-323) episodes to 45 (22-139) ( P =0.0003) ( Figure 2 ). Sixteen of the 31 patients had a reduction in the number of SGBs by more than 50% relative to baseline. (Example tracing, Figure 3 ) .
Th e number of SGB was reduced by 66% (43-91%) in patients with predominant belching ( n =15) and by 39% (1-78) in patients with predominant refl ux symptoms ( n =16) ( P =0.09).
At pre-treatment evaluation, the number of gastric belches represented 3.7% (5-12%) of the total number of belches in all patients. CBT treatment slightly increased the number of gastric belches from a median of 6 (1.5-15.5) episodes to 9 (4.25-17) ( P =0.01).
Th e total number of acid and non acid refl ux episodes was signifi cantly reduced from 71±43 at baseline to 54±39 post CBT ( P =0.0055). Th e acid refl ux episodes were signifi cantly reduced from 42±30 at baseline to 27±20 post CBT ( P =0.0002).
In the patients with increased SGBs and pathological acid exposure, we assessed the acid refl ux episodes associated with SGBs ( Figure 4 ). Seventeen out of 31 patients had pathological acid exposure at baseline (9.0±3.2%). In these patients, acid refl ux associated with SGBs contributed to a median of 26% of the total AET (range 1% to 100% of the 24-hour acid exposure). Of those 17 patients with pathological acid exposure at baseline there was a signifi cant reduction in acid exposure from 9.0±3.2% to 6.1±3.5% ( P =0.0053).
In patients that had improvement in AET the mean acid clearance time before CBT was 107 s (83-196) and aft er CBT was 96 s (67-116) P =0.12.
Outcome Subjective evaluation
Personality and hypervigilance in patients with pathological SGB . Compared to the general population, ( 17 ) and contrary to study expectations, our patients with pathological SGB scored higher on the BFI-10 on agreeableness (3.7±0.7 vs 3.2±0.8, P <0.001) but lower on neuroticism (3.1±1.1 vs 3.5±0.8, P <0.05) and openness (3.2±0.8 vs 3.4±0.9, P <0.05) Th e mean SSAS (hypervigilance) score for our cohort was 28.95. Th is score was within the average normal range (23) (24) (25) (26) (27) (28) .
Severity of belching (VAS scores)
. Th e self-reported severity of belching improved signifi cantly with CBT treatment ( Table 1 ) . Th e VAS composite scores decreased from 260 (210-320) to 140 (80-210); P <0.0001. Half of the patients (51%) had a reduction of at least 50% in their VAS composite scores ( Figure 5 ) .
Th e VAS scores decreased by 53% (36-65%) in patients with predominant belching ( n =15) and by 50% (12-64%) in patients with predominant refl ux symptoms ( n =16)
QOL (SF-36 scores) .
All patients with pathological SGB reported an impaired QOL before CBT. Compared to normal values from the British population, patients with pathological SGB scored lower in all domains. Aft er CBT treatment, the parameters of physical function, general health, vitality and social function improved signifi cantly ( P <0.05) ( Table 2 ) . Despite these improvements, the SF-36 scores post treatment remained signifi cantly lower than the UK normative values for all domains.
DISCUSSION
Excessive belching is a frequently reported symptom in patients with upper gasterointestinal disorders.( 1,2 ) Furthermore, belching can be associated with increased acid gastroesophageal refl ux. ( 5 ) Esophageal impedance monitoring allows distinction between gastric and SGB, ( 29 ) the fi rst being related to physiological gastric venting during transient relaxation of the lower esophageal sphincters and the second being a behavioral condition associated to rapid intraesophageal movement of air. In this study, we assessed the eff ectiveness of cognitive behavioral therapy in reducing pathological SGB, and investigated whether CBT-induced reduction in SGB can decrease acid gastroesophageal refl ux.
Our study confi rmed that patients with untreated pathological SGB have impaired QOL, and some patients are additionally burdened with SGB-driven pathological acid GER. Our study showed that patients who completed treatment experienced a signifi cant 
ESOPHAGUS
Supragastric Belching Treatment with Cognitive Behavioral Therapy
Hemmink et al. ( 23 ) , used speech therapy and showed that 6 of 11 patients had a signifi cant decrease of symptom severity (>30%). Katzka et al. ( 14 ) reported a case series of fi ve patients who had a positive response using a simple technique based on diaphragmatic breathing and exercising slight mouth opening to prevent. Blondeau et al. ( 9 ) studied the eff ect of baclofen in patients with suspected rumination syndrome and/or SGB. In their study, belching was the predominant symptom in only 2 of the 12 patients and SGB episodes did not decrease signifi cantly with baclofen. Finally, Kunte et al. ( 10 ) published a case report of a patient with severe belching who responded to combination of baclofen and pregabalin. benefi t from CBT owing to (a) reduction in the number of SGBs, (b) reduction in the number of acid refl ux episodes and total esophageal acid exposure (in patients in whom SGBs contributed signifi cantly to the acid burden), and (c) improved perception of the severity of belching and overall QOL.
To our knowledge, our study describes the largest series to date of patients treated with CBT for pathological SGB. Th is is also the fi rst study to systematically evaluate both subjective and objective parameters pre-and post-treatment for SGB, including the use of repeat 24 h MII-pH post-treatment to quantify both belching and acid refl ux outcomes. Of particular importance in our study was the identifi cation of the warning signal preceding the belch, which proved to be a critical stage to the behavioral treatment of SGB. Patients were asked to self-monitor the sensations preceding the belch. Th is allowed patients to increase their awareness of the antecedents prior to the onset of the belching and use this information to implement the treatment exercises to prevent the belch from eventuating. Th e majority of participants in our study were able to identify an antecedent to the belch, with 32 of the 39 patients reporting a preceding sensation, commonly described as a pressure or tension building in the thorax or above the diaphragm. Helping SGB patients to become more aware of signals and sensations that lead to belching enables greater opportunity to implement a competing response, namely the breathing exercises, to prevent the belch occurring.
Our treatment with CBT was effi cient to reduce signifi cantly the number of SGBs in more than half of the patients that completed the protocol. Th is eff ect was also observed in the subgroup of patients with moderate number of SGB (<75/24 h). Our study confi rms previous reports that SGB patients have impaired QOL, particularly in their social function. ( 2 ) Th e patient-reported severity of belching symptoms (as measured by VAS scores) improved signifi cantly upon completion of the CBT program. Indeed over half experienced >50% subjective improvement, which is a clinically important outcome. Th is eff ect was similarly observed in both, patients with predominant belching and patients with predominant refl ux symptoms. Patients felt less distressed, they had more control over belching, and this improvement impacted their social functioning and daily activities. Patients largely reported that mastery of the treatment exercises gave them a greater confi dence to control the belching in various settings. Th is increased their ability to engage in social activities and reduced the stigma and embarrassment previously experienced. Th is was refl ected to some extent in the SF-36 psychological domains that improved signifi cantly in the subscales of vitality and social functioning, indicating that patients experienced increased energy levels, reduced fatigue, and lessened impact of ill health on social activities following the CBT intervention. However, the mental health subscale measuring psychological distress attained a small improvement with CBT. Although this is used as a screening tool for anxiety, depression, or the presence of a mental disorder ( 25 ) , a specifi c measurement for anxiety or depression may have captured these changes in psychological distress more eff ectively.
Personality factors, especially neuroticism and hypervigilance, are commonly associated with functional gastrointestinal disorders (26) (27) (28) 30, 31 ) . Surprisingly, our cohort of patients with SGB displayed lower levels of neuroticism, indicating that they are less likely to respond in an anxious or negative manner to their symptoms. Moreover, higher levels of agreeableness and lower openness scores were observed compared to the general population. Further studies using a more comprehensive personality assessment would enhance our knowledge of personality traits associated with SGB.
Th e fi nding that hypervigilance to bodily sensations was within the normal range in patients with SGB was not as we expected, as research has shown increased hypervigilance to contribute to the development and maintenance of functional gasterointestinal disorders. ( 32,33 ) On refl ection, one possible explanation is that our study design investigated the general construct of hypervigilance to bodily sensations rather than specifi c hypervigilance to a particular sensation, as was previously found for esophageal hypervigilance. ( 33 ) Future investigations into symptom-specifi c hypervigilance may provide further insight into the psychosocial factors contributing to SGB. Cultural diff erences in the perception of bodily sensations and whether these are reported as disturbing may have also contributed to these results.
We acknowledge the following limitations of our study. An important limitation of this study is the lack of a comparative treatment arm. Indeed, we performed a per protocol analysis. We considered this as a "pilot study" and based on our positive results we are now starting a new controlled trial with a comparative treatment arm. Th e results presented were obtained from patients that completed the CBT protocol. Th e exclusion of patients who did not complete
In patients with predominant belching, the reduction of SGB was slightly higher than that observed in patients with predominant refl ux symptoms. However, this diff erence did not reach statistical signifi cance. It is important to acknowledge that although a significant number of patients had >50% reduction of SGBs, almost none of them had a completely normal second MII-pH recording. Like healthy subjects and patients with GERD, our patients had a small number of gastric belches (relative to the total amount of belches), being most of them postprandial and probably occurring during TLESRs. CBT treatment did not reduce the number of gastric belches. If anything, we noticed a small increase of gastric belches, unlikely to have an impact in symptoms or esophageal acid exposure.
Hemmink et al. ( 9 ) previously described the association between SGB and acid gastroesophageal refl ux. Subsequently, our group described a subgroup of patients where up to a third of their esophageal acid burden was owing to acid refl ux episodes associated with SGBs. ( 5 ) In the current study we show, for the fi rst time, that treatment of SGB with CBT can reduce daytime esophageal acid exposure. Th is further strengthens the case for a causal relantionship between supragatric belching and refl ux in some patients. In most of these patients this was attributable to concomitant reduction of SGBs and acid refl ux episodes; however, four patients still demonstrated decreased esophageal acid exposure without reduction in number of SGBs. It is possible that in these patients the diaphragmatic breathing exercises alone are suffi cient to reinforce the antirefl ux barrier as suggested by Eherer et al. ( 24 ) .
PPIs and/or antirefl ux surgery are the mainstays of treatment for patients with symptoms and objective demonstration of gastroesophageal refl ux disease. However, our study suggests that careful analysis of MII-pH tracings allows identifi cation of a subgroup of gastroesophageal refl ux disease patients with acid refl ux predominantly driven by SGB. In these patients, CBT can be a useful noninvasive adjunct that can at least partially reduce daytime esophageal acid exposure and may therefore reduce PPI requirements.
We postulate that CBT for SGB may also have a role in some gastroesophageal refl ux disease patients undergoing anti-refl ux surgery. A study by Broeders et al. ( 7 ) found that the frequency of SGBs increased post-operatively: this was thought to represent the futile eff orts of such patients to vent air from the stomach in lieu treatment due to patient unavailability or reluctance may have resulted in selection bias as patients who do not derive benefi t from treatment are more likely to drop out. We believe that recruitment of a sham controlled study would be diffi cult in this cohort of patients, especially since there is preliminary data suggesting effi cacy of CBT. Th us far we have only evaluated and described treatment outcomes at 8-week follow-up; further data collection is scheduled for the 1-year time point to establish longer term effi cacy.
CONCLUSION
Cognitive behavioral therapy ameliorated SGB in patients who completed treatment. It reduced the number of belches and improved social and daily activities in 50% of patients. Careful analysis of MII-pH allows identifi cation of a subgroup of gastroesophageal refl ux disease patients with acid refl ux predominantly driven by SGB. In these patients, CBT can reduce daytime esophageal acid exposure.
